Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Research and Development
HudsonAlpha Institute gets $2.9M NIH grant for pediatric rare disease sequencing
By
LabPulse.com staff writers
Scientists at the HudsonAlpha Institute for Biotechnology in Huntsville, AL, have been awarded a five-year, $2.9 million U.S. National Institutes of Health (NIH) grant to identify genetic contributors to rare diseases in children.
September 6, 2024
Seegene, Springer Nature launch PCR innovation program
By
LabPulse.com staff writers
Molecular diagnostics firm Seegene and Springer Nature have launched a new project for the development of diagnostic assays, as part of their ongoing strategic partnership.
September 3, 2024
Lumos Diagnostics extends deal to advance POC liver monitoring test to trials
By
LabPulse.com staff writers
Lumos Diagnostics is expanding an existing deal with the Burnet Diagnostics Initiative that will advance a new point-of-care (POC) test for monitoring liver health in an upcoming clinical trial.
August 28, 2024
Qiagen ventures into chronic disease CDx
By
LabPulse.com staff writers
Qiagen has expanded its agreement with AstraZeneca beyond oncology.
August 29, 2024
Scale Bio launches 100M cell challenge research initiative
By
LabPulse.com staff writers
Scale Biosciences, in collaboration with Ultima Genomics and Nvidia, has launched a global initiative for single-cell research projects aimed at collectively analyzing 100 million cells or more across diverse biological systems and research areas.
August 19, 2024
Alpenglow Biosciences lands $24M for 3D pathology platform
By
LabPulse.com staff writers
Company gets boost to commercialize direct-to-digital pathology platform and AI.
August 15, 2024
EnPlusOne, Wyss Institute collaborate on disease-agnostic RNA therapeutic
By
LabPulse.com staff writers
EnPlusOne Biosciences and the Wyss Institute are collaborating on a research initiative to develop a rapid, effectively deployable disease-agnostic RNA therapeutic.
August 16, 2024
Tulane advances digital microscopy imaging system
By
LabPulse.com staff writers
The bedside scanning device could eventually enable slide-free pathology.
August 14, 2024
Enzo takes $4.5M hit for lab data breach enabled by cybersecurity deficiencies
By
LabPulse.com staff writers
Lab testing company's vulnerabilities cited as contributing to 2023 attack exposing health information of millions.
August 14, 2024
Accelerate Diagnostics completes preclinical trial for antimicrobial test system
By
LabPulse.com staff writers
Accelerate Diagnostics successfully completed the preclinical trial of its WAVE antimicrobial susceptibility testing system.
August 12, 2024
Invenio enrolls 1st patients in AI-based lung cancer image analysis study
By
LabPulse.com staff writers
Invenio Imaging has begun enrolling patients in a pivotal study of its artificial intelligence (AI)-based image analysis module for lung cancer.
August 9, 2024
TCET reinforces MAC, MolDx reviews of IVD products, diagnostic laboratory tests
By
Liz Carey
Anticipated result of new coverage pathway would be faster access to technologies within a predictable coverage framework that generates clinical evidence for the Medicare population.
August 8, 2024
Page 1 of 41
Next Page